ES2058807T3 - Un metodo para la preparacion de un preparado para su administracion externa. - Google Patents

Un metodo para la preparacion de un preparado para su administracion externa.

Info

Publication number
ES2058807T3
ES2058807T3 ES90309439T ES90309439T ES2058807T3 ES 2058807 T3 ES2058807 T3 ES 2058807T3 ES 90309439 T ES90309439 T ES 90309439T ES 90309439 T ES90309439 T ES 90309439T ES 2058807 T3 ES2058807 T3 ES 2058807T3
Authority
ES
Spain
Prior art keywords
preparation
acid esters
external administration
amusulosin
dysuria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90309439T
Other languages
English (en)
Inventor
Yutaka Konno
Masataka Katsuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2058807T3 publication Critical patent/ES2058807T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA PREPARACION EXTERNA, PARA EL TRATAMIENTO DE DISURIA O ENFERMEDADES DEL TRACTO URINARIO INFERIOR, LA CUAL CONTIENE 1) AL MENOS UN COMPUESTO SELECCIONADO ENTRE AMUSULOSINA Y SUS SALES; 2) ALCOHOL ACUOSO, Y 3) AL MENOS UN AGENTE PROMOTOR DE ABSORCION TRANSDERMAL SELECCIONADO ENTRE DIESTERES ALIFATICOS DE ACIDO CARBOXILICO, ESTERES DE ACIDO NICOTINICO Y ESTERES DE ACIDO ISONICOTINICO, CON O SIN ADICCION DE TERPENO.
ES90309439T 1989-09-04 1990-08-29 Un metodo para la preparacion de un preparado para su administracion externa. Expired - Lifetime ES2058807T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22757589 1989-09-04

Publications (1)

Publication Number Publication Date
ES2058807T3 true ES2058807T3 (es) 1994-11-01

Family

ID=16863065

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90309439T Expired - Lifetime ES2058807T3 (es) 1989-09-04 1990-08-29 Un metodo para la preparacion de un preparado para su administracion externa.

Country Status (9)

Country Link
EP (1) EP0416804B1 (es)
JP (1) JPH03173816A (es)
KR (1) KR910005857A (es)
AT (1) ATE89719T1 (es)
CA (1) CA2024438A1 (es)
DE (1) DE69001734T2 (es)
DK (1) DK0416804T3 (es)
ES (1) ES2058807T3 (es)
IE (1) IE64061B1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153882A1 (en) * 1993-01-21 1994-08-04 Masataka Katsuma Novel transdermal absorption preparation
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
KR100309595B1 (ko) * 1998-12-05 2001-12-17 강성일 브라운관검사용소켓삽입장치
KR20020016944A (ko) * 1999-08-09 2002-03-06 오노다 마사요시 하부 요로증 치료용 의약 조성물
EP1938808B1 (en) * 2005-08-22 2011-01-12 Hisamitsu Pharmaceutical Co., Inc. Preparation for external use comprising tamsulosin
WO2011105486A1 (ja) 2010-02-24 2011-09-01 久光製薬株式会社 貼付剤
US10137098B2 (en) 2014-05-28 2018-11-27 Teikoku Seiyaku Co., Ltd. Transdermal preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
DE3570598D1 (en) * 1984-11-15 1989-07-06 Nitto Denko Corp Composition for percutaneous administration
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation

Also Published As

Publication number Publication date
KR910005857A (ko) 1991-04-27
DE69001734D1 (de) 1993-07-01
EP0416804A1 (en) 1991-03-13
JPH03173816A (ja) 1991-07-29
EP0416804B1 (en) 1993-05-26
IE903134A1 (en) 1991-03-13
DK0416804T3 (da) 1993-06-21
IE64061B1 (en) 1995-07-12
CA2024438A1 (en) 1991-03-05
DE69001734T2 (de) 1993-09-02
ATE89719T1 (de) 1993-06-15

Similar Documents

Publication Publication Date Title
NL930009I2 (nl) 6(R)-Ä2-(8'-Acyloxy-2'-methyl-6'-methyl (of waterstof)-poly-hydronafty-1')-ethylÜ-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-onen, de hydroxyzuurvorm van deze pyranonen, de farmaceutisch aanvardbare zouten van genoemde hydroxyzuren, en de door kleinealkyl- en fenyl-, dimethylamino- of acetylaminore sten gesubstitueerde klein-alkylesters van genoemdhydroxyzuur, werkwijzen ter bereiding ervan en ee n farmaceutisch antihypercholesterolemisch preparaat, dat dit bevat.
SE8403487L (sv) Farmaceutisk komposition
ES2120562T3 (es) Composicion farmaceutica de liberacion sostenida.
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
AU1331588A (en) Method for treatment of alcohol abuse
ES2058807T3 (es) Un metodo para la preparacion de un preparado para su administracion externa.
DE3778132D1 (de) 2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester.
MX9205313A (es) Composicion farmaceutica que comprende una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico, con antibioticos y metodo para preparar la misma
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
DK585889A (da) Farmaceutisk praeparat
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
IT1283225B1 (it) Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
NO912545L (no) Nye 3,3'-ditiobis(propionsyrer) og estere derav samt fremgangsmaate for deres fremstilling
FR2681863B1 (fr) Solution de sparfloxacine sa preparation et sel la constituant.
NO175637C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav
NO903058L (no) Farmasoeytisk preparat med forbedret absorberbarhet.
ES2045653T3 (es) Sales cristalinas por adicion de acidos de cefem y procedimiento para su preparacion.
ES2115916T3 (es) Procedimiento para la preparacion de compuestos de triazolona.
FR2686876B1 (fr) Procede de preparation d'acides arylacetiques et de leurs sels de metaux alcalins.
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
ATE89563T1 (de) Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
DK192487D0 (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
ATE23161T1 (de) 3-deazaguanin-sulfonsaeuresalze.
ATE129244T1 (de) 4-((thiophen-2-carbonyl)oxy>pyrrolidin-2- carbonsäure, deren herstellung und deren verwendung als entzündungshemmendes und wundheilendes mittel.
IE870122L (en) Treatment of coronary disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 416804

Country of ref document: ES